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Abstract
The pleckstrin-homology-domain-containing protein PLEKHA7 was recently identified as a protein linking the E-cadherin-
p120 ctn complex to the microtubule cytoskeleton. Here we characterize the expression, tissue distribution and subcellular
localization of PLEKHA7 by immunoblotting, immunofluorescence microscopy, immunoelectron microscopy, and northern
blotting in mammalian tissues. Anti-PLEKHA7 antibodies label the junctional regions of cultured kidney epithelial cells by
immunofluorescence microscopy, and major polypeptides of Mr ,135 kDa and ,145 kDa by immunoblotting of lysates of
cells and tissues. Two PLEKHA7 transcripts (,5.5 kb and ,6.5 kb) are detected in epithelial tissues. PLEKHA7 is detected at
epithelial junctions in sections of kidney, liver, pancreas, intestine, retina, and cornea, and its tissue distribution and subcellular
localization are distinct from ZO-1. For example, PLEKHA7 is not detected within kidney glomeruli. Similarly to E-cadherin,
p120 ctn, b-catenin and a-catenin, PLEKHA7 is concentrated in the apical junctional belt, but unlike these adherens junction
markers, and similarly to afadin, PLEKHA7 is not localized along the lateral region of polarized epithelial cells. Immunoelectron
microscopy definitively establishes that PLEKHA7 is localized at the adherens junctions in colonic epithelial cells, at a mean
distance of 28 nm from the plasma membrane. In summary, we show that PLEKHA7 is a cytoplasmic component of the
epithelial adherens junction belt, with a subcellular localization and tissue distribution that is distinct from that of ZO-1 and
most AJ proteins, and we provide the first description of its distribution and localization in several tissues.
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Introduction
Epithelial cells are characterized by an apical junctional complex,
comprising tight junctions (TJ), adherens junctions (AJ) and
desmosomes [1]. TJ and AJ are of critical importance in the
development and physiology of vertebrate epithelial tissues. TJ
control the barrier function of epithelia and maintain cell polarity,
and AJ regulate cell-cell adhesion and morphogenesis [2,3]. The
molecular architecture of TJ and AJ has been largely clarified in
recent years [4,5,6,7,8]: junctions comprise transmembrane pro-
teins that are linked to cytoskeletal filaments through a cytoplasmic
plaque, that contains scaffolding, adaptor and signaling proteins.
The cytoskeleton plays a fundamentalrole in the regulationof the
assembly and function of TJ and AJ. Actomyosin filaments
modulate the TJ barrier and orchestrate the signaling and adhesive
functions of AJ, through the interaction with several actin-binding
junctional proteins, including Zonula-Occludens-1 (ZO-1), a-
catenin, and afadin [9,10,11,12]. Microtubules are implicated in
membrane remodeling and polarized vesicle traffic, influencing the
barrier and adhesive functions of TJ and AJ [13,14,15,16]. Little is
known about the molecules that interact with microtubules at
epithelial junctions [16,17,18]. Recently, it was shown that E-
cadherin, the major transmembrane protein of AJ, associates with
microtubules through a protein complex comprising p120 ctn, and
the newly identified proteins PLEKHA7 and nezha [19]. Although
it was shown that PLEKHA7 partially co-localizes with E-cadherin
in cultured intestinal cells [19], nothing is known about its pattern of
expression and its subcellular localization in epithelial tissues.
Furthermore, the localization of PLEKHA7 at the ultrastructural
level has not been determined in any tissue.
To address these questions, we used northern blot analysis,
immunoblotting, immunofluorescence and immunoelectron mi-
croscopy with specific antibodies that we generated and charac-
terized. The results show that PLEKHA7 is localized at epithelial
AJ, has a localization distinct from ZO-1 and most markers of the
AJ plaque, and exists in multiple isoforms.
Results
Specific antibodies against PLEKHA7 label the junctional
regions of cultured renal epithelial cells and detect Mr
,145 and ,135 kDa polypeptides in cell and tissue
lysates
PLEKHA7 contains two WW domains and one pleckstrin
homology (PH) domain in the N-terminal half, and coiled-coil (cc)
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12207and proline-rich domains in the C-terminal half of the molecule
(Fig. 1A) [19]. We generated polyclonal and monoclonal
antibodies against a C-terminal fragment of human PLEKHA7,
comprising one proline-rich and one coiled-coil domain (‘‘anti-
gen’’, Fig. 1A), fused to glutathione-S-transferase (GST). By
immunoblotting, the antibodies labelled a major polypeptide, with
an apparent size of Mr ,145 kDa in lysates of epithelial cells from
mouse (mpkCCDc14) and dog (MDCK) kidney, as well as the
antigen (,50 kDa) (Fig. 1B). The signal of the Mr ,145 kDa
polypeptide was decreased in MDCK cells depleted of PLEKHA7
by shRNA-mediated interference (Fig. 1C). The epitope recog-
nized by the monoclonal antibody was mapped within residues
920–1020, as determined by immunoblotting of bacterially
expressed fragments of the PLEKHA7 antigen (data not shown).
By immunofluorescence microscopy, the polyclonal antibodies
specifically labelled the region of cell-cell contact in MDCK cells
expressing exogenous human PLEKHA7, and the endogenous
protein in mpkCCDc14 cells (Fig. 1D). These results are in
agreement with previous work, reporting the junctional localiza-
tion and molecular size of PLEKHA7 in cultured human intestinal
cells [19].
Immunoblot analysis of lysates of different epithelial tissues
(colon, liver, lung, eye, pancreas, kidney) and heart tissue showed
major polypeptides of Mr ,145 kDa and ,135 kDa (Fig. 1E,
and data not shown). A polypeptide with apparent size of Mr
,240 kDa was clearly labelled in lysates of pancreas, by both
polyclonal antiserum and monoclonal antibody, and was also
detectable in lysates of lung, eye and liver (Fig. 1E, and data not
shown). Such large polypeptide was not detected in lysates of
cultured cell lines, and its detection is probably due to the
presence of cross-reacting epitopes in an unrelated protein (see
Discussion).
Figure 1. Characterization of anti-PLEKHA7 antibodies, and expression of PLEKHA7 in cells and tissues. A. Schematic diagram of the
domain organization of PLEKHA7, showing WW, pleckstrin-homology (PH), proline-rich (Pro), and coiled-coil (cc) domains. The C-terminal region
comprising the sequences of PLEKHA7 used to generate the GST-fusion protein is indicated (antigen, residues 821–1121). B. Immunoblotting analysis
of lysates of mouse (mpkCCDc14) and dog (MDCK) renal epithelial cells, and PLEKHA7 antigen (see (A)) using rabbit immune and pre-immune sera,
and mouse monoclonal antibody 16G2. A polypeptide of Mr ,145 kDa and the antigen (, 50 kDa) are specifically labeled by both antibodies. In
addition, the immune serum labels additional polypeptides of smaller size, which may in part derive from proteolytic degradation of full-length
PLEKHA7, and in part from non-specific cross-reaction. Apparent sizes of molecular size markers are indicated (kDa). C. Immunoblotting analysis of
lysates of three clonal lines of MDCK cells depleted of PLEKHA7 by shRNA-mediated silencing, using the monoclonal antibody 16G2, or anti-b-tubulin
antibodies (to normalize protein loadings). D. Immunofluorescence microscopy analysis of exogenous human PLEKHA7 expressed in canine MDCK
cells (left) and endogenous PLEKHA7 in mouse mpkCCDc14 cells (right), using either immune or pre-immune rabbit serum (Bar=15 mm). Note that by
immunofluorescence microscopy the rabbit immune serum does not recognize canine PLEKHA7, but only the exogenously expressed human protein.
E. Immunoblotting analysis of PLEKHA7 in lysates of epithelial tissues, using either polyclonal anti-PLEKHA7 immune serum, or anti-b-tubulin
antibodies. Arrowheads on the right indicate major polypeptides labeled by the polyclonal antiserum, with apparent sizes of Mr ,240 kDa, Mr
,145 kDa, and Mr ,135 kDa. F. Northern blot analysis of a human multiple tissue array of total RNA, hybridized using specific PLEKHA7 (top panel)
and actin (bottom panel) DIG-labelled probes. Arrowheads on the right indicate that PLEKHA7 mRNA is detected as two bands of ,5.5 kb and
,6.5 kb.
doi:10.1371/journal.pone.0012207.g001
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PLEKHA7 transcripts, we performed a northern blot analysis of
RNA from several tissues. PLEKHA7 mRNA was detected as two
major transcripts, with apparent sizes of ,5.5 kb and ,6.5 kb, in
brain, kidney, liver, small intestine, placenta and lung, and as one
major transcript of 5.5 kb in the heart and other tissues (Fig. 1F).
Signal intensity was high in the placenta, kidney and heart samples,
and low in brain, colon, liver, skeletal muscle, spleen, small intestine
and lung samples, whereas no signal was detected in thymus and
leukocytes samples (Fig. 1F). Taken together, these results show that
the antibodies that we generated are specific for PLEKHA7, and
indicate that PLEKHA7 exists in multiple isoforms.
The tissue distribution and junctional localization of
PLEKHA7 in epithelial tissues is distinct from ZO-1
To determine the localization of PLEKHA7, frozen sections of
epithelial tissues and heart sections were labeled with anti-
PLEKHA7 antibodies. Immunofluorescence microscopy analysis
showed labeling of junctions in the kidney, pancreas, liver,
duodenum, ileum, retina, and lung (Fig. 2, and data not shown).
In the kidney cortex, epithelial cells of convoluted tubules were
labeled, with a subset of tubules displaying slightly weaker staining
(arrowhead in Fig. 2A) than others (arrow in Fig. 2A). In the
pancreas, epithelial cells of the acini and ductules showed positive
staining (arrow in Fig. 2B), whereas no labeling of the islets of
Langerhans was detected (data not shown). Similarly, in sections of
liver, labeling was detected along the junctions between epithelial
cells lining bile canaliculi (arrow in Fig. 2C). In the duodenum
(Fig. 2D), colon and ileum (see below and data not shown),
labeling appeared as a thin apical bar in longitudinal sections
(arrowhead in Fig. 2D), and as a net-like meshwork in tangential
sections (arrow in Fig. 2D, and data not shown) of enterocytes. In
heart sections, anti-PLEKHA7 antibodies gave diffuse staining of
cardiac myocites, without any accumulation at identifiable
structures (Fig. 2E), whereas in the same sections anti-cadherin
antibodies prominently labeled the intercalated disks between
cardiac myocites (Fig. 2E9). In the retina, labeling was detected in
the outer limiting membrane (OLM) (arrowhead in Fig. 2F), which
has been previously shown to contain both AJ and TJ proteins
[20], and along the junctions between retinal pigmented epithelial
cells (arrow in Fig. 2F). No PLEKHA7 staining was detected in
sections of spleen (data not shown).
Next, we asked whether the distribution and localization of
PLEKHA7 was distinguishable from that of ZO-1, a protein that is
localized at TJ in polarized epithelial cells, and at AJ in non-
epithelial cells [21,22,23]. Double immunofluorescence microsco-
py showed that in the kidney cortex strong ZO-1 labeling was co-
localized with PLEKHA7 in epithelial cells lining the tubules
(arrow in Fig. 3A-A0), and ZO-1 labeling was weaker in the subset
of tubules, that displayed stronger PLEKHA7 labeling (double
arrowheads in Fig. 3A-A0). In addition, ZO-1 labeling was
detected within glomeruli, in agreement with previous studies,
showing that ZO-1 is localized at podocyte filtration slits [24],
whereas no PLEKHA7 labeling was detected within glomeruli
(arrowhead in Fig. 3A-A0). In corneal tissue, ZO-1 and PLEKHA7
were co-localized linearly along junctions in the outermost layer of
the stratified epithelium (arrow in Fig. 3B-B0), whereas only
PLEKHA7 was detected in the basal layer of the epithelium, in a
punctate, discontinuous pattern (arrowhead in Fig. 3B-B0). In
sections of brain tissue, ZO-1 labeling was detected in short linear
segments, that may correspond to endothelial junctions of blood
vessels, but no corresponding PLEKHA7 labeling was detectable
at these sites (arrowhead in Fig. 3C-C0). Tangential sections of the
duodenum showed a very similar distribution of ZO-1 and
PLEKHA7 (Fig. 3D-D0). However, the labeling for the two
proteins could be spatially distinguished given the appropriate
section orientation (arrowhead, and magnified inset in Fig. 3D-
D0). Finally, the intensity of labeling for both PLEKHA7 and
ZO-1 was strong in the basal, crypt areas of intestinal villi (arrows
in Fig. 3E-E’’). In contrast to the staining in the crypts, the apical
region of the villi showed a weaker labeling for PLEKHA7,
whereas the labeling for ZO-1 was of similar intensity throughout
the villus (arrowheads in Fig. 3F-F’’). In summary, the pattern of
tissue distribution and subcellular localization of PLEKHA7 is
distinct from that of ZO-1.
In epithelial cells, PLEKHA7 is restricted to the AJ apical
belt, and is absent from the lateral membrane
To further examine the junctional localization of PLEKHA7,
we examined by double immunofluorescence microscopy tissue
sections stained with antibodies against PLEKHA7 and several
markers of AJ [6,25], including the transmembrane protein E-
cadherin, and several cytoplasmic plaque AJ proteins: 1) a-catenin,
which interacts with the cytoplasmic domain of E-cadherin
through b-catenin; 2) b-catenin, which interacts with E-cadherin
and a-catenin; 3) p120 ctn, which interacts with the juxtamem-
brane region of E-cadherin, and with PLEKHA7 [19]; 4) afadin,
which interacts with nectin and a-catenin [12].
In sections of colonic villi, PLEKHA7 colocalized at the apical
junctions of enterocytes with E-cadherin (arrowhead in Fig. 4A-
A0), p120 ctn (arrowhead in Fig. 4B-B0), afadin (arrowhead in
Fig. 4C-C0) and a-catenin (arrowhead in Fig. 4D-D0). However,
antibodies against E-cadherin (Fig. 4A9), p120ctn (Fig. 4B9) and a-
catenin (Fig. 4D), as well as phalloidin and antibodies against b-
catenin (data not shown) also labeled the lateral membrane,
whereas no labeling for PLEKHA7 was detected in this region
(arrows in Fig. 4A-A0, B-B0, D-D0). Conversely, afadin labeling
was absent from the lateral membrane, similarly to PLEKHA7,
indicating that afadin and PLEKHA7 have an identical localiza-
tion in these cells (Fig. 4C-C0). However, while afadin was also
detected within the villus stroma, presumably along junctions
between endothelial cells of lymph vessels, no corresponding
labeling for PLEKHA7 was detected (arrows in Fig. 4C-C0). To
further examine the localization of PLEKHA7 in blood vessels, we
examined its co-localization with the endothelial cell marker
PECAM-1. In sections of the intestine near the crypts, the
junctions of epithelial cells within the crypts were clearly labeled by
anti-PLEKHA7 antibodies (arrowheads in Fig. 4E9-E0), whereas
blood vessels showed strong PECAM-1 staining, and very weak
PLEKHA7 staining (arrows in Fig. 4E-E0).
In bronchial epithelial cells, PLEKHA7 colocalized at apical
junctions, but not along the lateral membrane, with p120 ctn
(Fig. 5A-A0), b-catenin (Fig. 5B-B0), and E-cadherin (Fig. 5E-I),
and showed a localization very similar to afadin (Fig. 5D-D0).
Actin filaments were also detected at apical junctions (arrowhead
in Fig. 5C-C0) and along lateral membranes, and at this latter
location they were not colocalized with PLEKHA7 (arrows in
Fig. 5C-C0). In the lung, PLEKHA7 labeling was also detected in
the junctions of alveolar pneumocytes (data not shown). Exami-
nation of magnified areas of bronchial cells that were double-
labelled for E-cadherin and PLEKHA7 showed that the region of
colocalization (arrowheads in Fig. 5E, F, G, H, I) was flanked
apically by a region containing PLEKHA7 labeling, but devoid of
E-cadherin labeling (asterisks in Fig. 5E, F, G, H, I), and basally by
a region that contained only E-cadherin labeling (arrows in Fig. 5E,
F, G, H, I). These observations suggested that in these cells
PLEKHA7 accumulates at the AJ belt, and extends slighly more
apically than other AJ plaque proteins, suggesting that PLEKHA7
PLEKHA7 Localization
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distribution of PLEKHA7 and ZO-1 along the apical borders of
bronchial cells was very similar and partially overlapping, close
inspection of appropriately tilted sections showed that the two
proteins were localized in adjacent, but separate areas of the
junction (Fig. 5J-K), confirming that the localizations of PLE-
KHA7 and ZO-1 are distinct.
Finally, we determined the localization of PLEKHA7 at the
ultrastructural level. Immunoelectron microscopy showed that
PLEKHA7 labeling was accumulated at the cytoplasmic face of
the AJ in intestinal epithelial cells (Fig. 6A). Among particles that
were detected in the proximity of the plasma membrane (n=241
out of 298 total), 78% were associated with the AJ, 3.7% with the
TJ, 2% with the desmosome, 7.5% with the apical membrane and
microvilli, and 7.9% with other areas. The mean distance of the
gold particles from the AJ membrane was 28 nm (612 nm,
n=188) (Fig. 6B), suggesting a close association of PLEKHA7
with the junctional membrane. Taken together, the immunoflu-
orescence and immunoelectron microscopy data show that
PLEKHA7 is localized at the AJ belt of epithelial cells.
Figure 2. PLEKHA7 is localized at cell-cell junctions in epithelial tissues. Immunofluorescent analysis of PLEKHA7 distribution in kidney (A),
pancreas(B),liver(C),duodenum(D),heart(E)andretina(F),usingpolyclonalimmuneserum,andpan-cadherindistributioninheart(E9).Arrowsindicate
junctionsbetween epithelial cells, exceptin E9, where thearrow indicatesintercalateddisks. Thearrowheadin A indicates weaker junctional labeling in a
subset of cortical tubules. The arrowhead in D indicates apical staining in longitudinally sectioned columnar epithelial cells. The asterisk in D indicates
non-specific labeling of mucus in goblet cells. The arrowhead in F indicates staining in the outer limiting membrane of the retina. Bar=10 mm.
doi:10.1371/journal.pone.0012207.g002
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PLoS ONE | www.plosone.org 4 August 2010 | Volume 5 | Issue 8 | e12207Figure 3. The localization and distribution of PLEKHA7 and ZO-1 are distinct. Double immunofluorescence labeling of PLEKHA7 and ZO-1
in mouse kidney cortex (A-A’’), cornea (B-B’’), brain (C-C’’), and duodenum (D-D’’, E-E’’, F-F’’). Arrows indicate junctions where PLEKHA7 and ZO-1
labeling appear co-localized. Arrowheads indicate junctions that show stronger or only labeling for either PLEKHA7 (B-B’’) or ZO-1 (A-A’’, C-C’’, F-F’’).
Double arrowheads in A-A0 indicate kidney tubules that show weaker ZO-1 labeling. Merge images show nuclei labeled in blue by DAPI. Bar=10 mm.
doi:10.1371/journal.pone.0012207.g003
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PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12207Figure 4. PLEKHA7 colocalizes with AJ proteins at the apical AJ belt, but not along the lateral walls. Double immunofluorescence
labeling of sections of intestinal tissue with antibodies against PLEKHA7, together with antibodies against either E-cadherin (A-A’’), or p120ctn (B-B0),
or afadin (C-C0), or a-catenin (D-D0), or PECAM-1 (E-E0). Arrowheads indicate junctional labeling for PLEKHA7, that is colocalized with the AJ marker
(but not in E-E0). Arrows indicate staining of AJ markers along lateral walls (A-A0, B-B0, D-D0). The arrows in C-C0 indicate afadin labeling within the
villus stroma (presumably endothelial cells of lymphatic vessels), that is not colocalized with PLEKHA7. Arrows in E-E0 indicate PECAM-1-labeled blood
vessels that show very weak PLEKHA7 labeling. Merge images show nuclei labeled in blue by DAPI. Bar=10 mm.
doi:10.1371/journal.pone.0012207.g004
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PLoS ONE | www.plosone.org 6 August 2010 | Volume 5 | Issue 8 | e12207Figure 5. In bronchial epithelial cells PLEKHA7 colocalizes with AJ proteins, but does not localize along lateral walls. Double
immunofluorescence labeling of PLEKHA7 with p120ctn (A-A’’), b-catenin (B-B0), phalloidin (C-C0), afadin (D-D0), E-cadherin (E-I, merge images only),
and ZO-1 (J-K, merge images only) in sections of lung (bronchial cells). Arrowheads indicate colocalization between PLEKHA7 and AJ marker. Arrows
indicate staining of AJ markers along lateral walls, that is not colocalized with PLEKHA7, except for panels J-K, where arrows indicate apical staining
for ZO-1. Asterisks (E-K) indicate PLEKHA7 labeling apical to the region of colocalization with AJ markers at the AJ belt (E-I), and that is spatially
distinct from ZO-1 (J-K). Merge images show nuclei labeled in blue by DAPI. Bar=10 mm (A-D) and 0.5 mm (E-K).
doi:10.1371/journal.pone.0012207.g005
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Cell-cell junctions are heterogeneous in their morphology and
molecular makeup, even within a single tissue [26,27,28], and
mouse knockout studies show complex, redundant and non-
redundant roles for junctional proteins [29,30]. Thus, to clarify the
role of junctional molecules in physiology and pathology, it is
necessary to analyze systematically their expression, tissue
distribution and localization. Here, we aimed to characterize the
expression profile and the subcellular localization of PLEKHA7, a
recently identified p120ctn-associated protein, that plays a
fundamental role in tethering microtubule minus ends to the AJ
[19].
Previously, the AJ localization of PLEKHA7 was inferred in
cultured intestinal epithelial cells from the profile of distribution of
PLEKHA7 immunofluorescent labeling along the lateral mem-
brane, which was partially co-localized with E-cadherin [19].
However, nothing was known about the localization and
distribution of PLEKHA7 in tissues. Here, we establish by
immunoelectron microscopy that PLEKHA7 is localized at the
AJ belt in epithelial cells. In addition, we show by immunofluo-
rescence microscopy that PLEKHA7 is localized at cell-cell
junctions in several epithelial tissues, with a subcellular localization
and a tissue distribution that are distinct both from the TJ marker
ZO-1, and also from several protein markers of the AJ. Unlike E-
cadherin, p120ctn, a-catenin, and b-catenin, PLEKHA7 is absent
from the ‘‘puncta adherentia’’ along lateral walls of epithelial cells,
where a mobile pool of E-cadherin associates with many AJ plaque
proteins [31,32]. Why PLEKHA7 is not recruited to ‘‘puncta
adherentia’’ by its interacting partner p120ctn is unclear, but one
possibility is that the localization of PLEKHA7 and/or its
interaction with p120ctn requires a simultaneous interaction with
the microtubule cytoskeleton and/or associated proteins, which
can only occur at the AJ belt. Conversely, the subcellular
localization of PLEKHA7 in epithelial cells most closely resembles
that of afadin, an AJ plaque protein that links the transmembrane
protein nectin to the actin cytoskeleton, and also interacts with a-
catenin [12,25]. However, PLEKHA7 differs from afadin and
ZO-1, because it is not clearly detectable in junctions of
endothelial cells, that contain VE-cadherin, afadin and p120ctn
[33]. Future studies should investigate in more detail the
localization of PLEKHA7 in junctions of cells lining blood and
lymph vessels, and in the ‘‘complexus adherens’’, a unique type of
adherens junction present in the lymph node, that contains VE-
cadherin, as well as proteins of epithelial AJ, TJ and desmosomes
[34]. Apart from the localization of PLEKHA7 in the outer
limiting membrane of the retina, which contains heterotypic
junctions between glial and neuronal cells, our observations
suggest that the distribution of PLEKHA7 is essentially confined to
epithelial junctions. The lack of PLEKHA7 labeling in heart
intercalated disks, that contain cadherin and afadin [12] was
unexpected, considering that PLEKHA7 mRNA and protein were
detected in heart tissue by northern and western blotting. One
possibility to explain this observation is that the epitopes
recognized by our antibodies are modified in heart tissue, in a
way that negatively affects immunofluorescent labeling. In
summary, our observations indicate that PLEKHA7 is an AJ
protein with a unique combination of subcellular localization and
tissue distribution, since it is absent from puncta adherentia along
the lateral walls of epithelial cells, and its pattern of tissue
distribution is different from that of afadin.
We provide evidence that PLEKHA7 may exist in multiple
isoforms within tissues. By northern blotting analysis we detect two
major mRNAs species of PLEKHA7, with sizes of of ,5.5 kb and
,6.5 kb. In lysates of epithelial tissues, we identify by immuno-
blotting major polypeptides of Mr ,135–145 kDa. A cross-
reacting slower mobility polypeptide (Mr ,240 kDa), prominently
detected in the pancreas, is probably an unrelated protein
recognized by anti-PLEKHA7 antibodies, based on two argu-
ments. First, the Mr ,240 kDa could not be immunoprecipitated
from cultured epithelial cells. Second, bioinformatic analysis
predicts two isoforms for human PLEKHA7 (both of Mr
,127 kDa) and five isoforms for mouse PLEKHA7 (Mr ,127,
,144, ,115, ,117, ,107 kDa), none of which corresponds to a
,240 kDa molecular size. However, we cannot exclude that the
slower migration of the Mr ,240 kDa polypeptide may be due to
post-translational modifications of the Mr ,145 kDa polypeptide,
that could occur in selected tissues. The functional significance of
the PLEKHA7 isoforms, and the role of PLEKHA7 in cell
differentiation should be clarified by future studies. For example,
the observation that PLEKHA7 labeling in intestinal cells is
stronger in the crypts rather than at the tip of the villi, suggests a
Figure 6. Ultrastructural localization of PLEKHA7 at AJ. (A) Immuno-gold electron microscopy localization of PLEKHA7 in mouse colon
epithelial cells. Tight junction (TJ), adherens junction (AJ) and desmosome (D) are indicated with brackets. Note the accumulation of particles at the
AJ. Bar=300 nm. (B) Histogram showing the distribution of immuno-gold particles associated with the AJ, as a function of the distance from the
plasma membrane (nm).
doi:10.1371/journal.pone.0012207.g006
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differentiation, similar to that described for several AJ and TJ
proteins [35].
PLEKHA7 has been proposed to regulate AJ stability through
its ability to link the microtubule cytoskeleton to E-cadherin [19],
and the E-cadherin/catenin/cytoskeleton complex is a crucial
regulator of cancer invasion [36]. Thus, a question that should be
addressed using cellular and animal model systems is whether AJ
stabilization through PLEKHA7-dependent microtubule anchor-
ing is important in cancer development and progression. Specific
antibodies against PLEKHA7 will be a valuable tool for this
purpose, and could also be useful in the histological typing and
diagnosis of tumors.
Materials and Methods
Antibodies
To generate anti-PLEKHA7 antibodies, rabbits (New Zealand
White, Pocono Farms Research Laboratory, www.prfal.com) and
mice (Balb-c) were immunized by subcutaneous injection with an
affinity purified, bacterially expressed recombinant fusion protein,
comprising GST fused to a C-terminal fragment of human
PLEKHA7 (residues 821–1121). To generate the PLEKHA7
construct in the expression vector pGEX4T1, we used polymerase
chain reaction (PCR) amplification on a template of a full-length
human PLEKHA7 cDNA in the pSPORT6 vector (IR-
AKp961M14168Q, RZPD www.imagenes-bio.de, corresponding
to Genbank sequences ID BC033239.1 and GI:23138763).
Truncated constructs of the antigen for epitope mapping purposes
were also generated by PCR. The rabbit polyclonal anti-
PLEKHA7 antiserum 20943 was used at a dilution of 1:250 for
immunofluorescence, and 1:10,000 for immunoblotting.
Experiments and protocols on mice were authorized by the
Geneva State Health Commission (Project name: ‘‘Production of
mouse monoclonal antibodies by immunization with cell-cell
junction proteins’’, authorization number 1010/3356/1 by Dr.
Astrid Rod of Direction Ge ´ne ´rale de la Sante ´, State of Geneva,
18.12.2007) and by the Ethics Committee for Animal Experimen-
tation of the University of Geneva (Protocol 09-27). Monoclonal
antibodies were obtained by fusion of NSO myeloma cells with
lymphocytes isolated from axillar and inguinal lymphnodes of
immune mice [37]. Hybridomas were screened by enzyme-linked
immunosorbent assay (ELISA), immunoblotting and immunoflu-
orescence microscopy, and two positive clones (16G2 and 378F1,
that gave identical reactivity by immunoblotting) were isolated by
limiting dilution, and were used as undiluted culture supernatants
for immunofluorescence, and diluted 1:100 for immunoblotting.
Other antibodies were: rat anti-ZO-1 (R40-76, from Dr. D.
Goodenough, Harvard Medical School, 1:50) [21], mouse anti-
E-cadherin (Becton Dickinson Switzerland BD610181), rabbit
anti-a-catenin (Sigma Switzerland C-2081, 1:100), mouse anti-
a-catenin (BD 610193, 1:50), rabbit anti-b-catenin (Sigma C2206,
1:100), mouse anti-p120ctn (15D2, from Dr. A. Reynolds,
Vanderbilt University, USA, 1:500) [38], rabbit anti-afadin (Sigma
A-0224, 1:500), rat anti-PECAM-1 (MEC13.3, BD 553370, 1:50).
TRITC-phalloidin was from Sigma (P-1951, 1:1000). Fluorescein
isothiocyanate (FITC)- and tetramethylrhodamine isothiocyanate
(TRITC)-labeled secondary antibodies for immunofluorescence
microscopy were from Jackson Immunoresearch Laboratories
Europe (www.JIREurope.com).
Northern blotting
A DNA probe of 1300 bp was generated using the DIG-PCR
amplification kit (Roche, Switzerland) with the primers 59-GAA
GAG CCG AAT CCA CAT ATG-39 and 59-CTG GCG CTG
CTG CCA CTC-39 and the full length human PLEKHA7 cDNA
as template. A human multiple tissue membrane (Clontech
Europe, cat. 636818) was hybridized with 250 ng/ml probe in
ExpressHybTM hybridization solution (Clontech) at 65uC over-
night. Washes were performed twice with SSC 26buffer (0.3 M
NaCl, 30 mM sodium citrate, pH 7.0, containing 0.1% SDS) for
5 min at room temperature, and with SSC 0.56buffer containing
0.1% SDS for 10 min at 60uC. Detection of hybridized probe was
achieved with anti-DIG-AP antibody (Roche) followed by
incubation in CSPD substrate (Roche), and exposure to X-ray
film. The membrane was stripped with DEPC water containing
0.1% SDS at 100uC, and probed with human beta-actin probe
(provided by Clontech), as a loading control.
Cell culture and transfection
MDCKII cells were cultured in DMEM medium supplemented
with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin and
16minimal essential medium (MEM) non essential amino acids.
mpkCCDc14 cells (mouse kidney distal tubule epithelial cells, a gift
from Dr. E. Feraille, University of Geneva) were cultured in 1:1
DMEM/HAMF12 medium, supplemented with 5 mg/ml insulin,
50 nM dexamethasone, 60 nM selenium, 5 mg/ml transferrin,
1 nM triiodothyronine, 10 ng/ml epidermal growth factor (EGF),
20 mM HEPES, 2 mM glutamine, 10% fetal bovine serum (FBS)
and 20 mM D-glucose.
For transfection, Lipofectamine 2000 (Invitrogen, Carlsbad,
California) was used, following the manufacturer’s instructions.
Myc-tagged full-length human PLEKHA7 was generated by
cloning the full-length sequence (see above) in the vector
pcDNA3.1myc-His. Cells were analyzed by immunofluorescence
microscopy 48 h after transfection.
The generation and characterization of cells depleted of
PLEKHA7 by expression of shRNA will be described elsewhere
(Pulimeno et al, unpublished data).
Immunoflurescence microscopy and immunoblotting
Cells on glass coverslips were fixed with cold methanol for
10 min at 220uC, washed three times with PBS, incubated with
primary antibody (1 hr at 30uC), washed, incubated with
secondary antibody (30 min at 37uC), washed and mounted with
Vectashield medium (Reactolab, Servion, Switzerland). For
immunohistochemistry, frozen sections (5 mm) were obtained from
tissues included in OCT medium and snap-frozen in liquid
nitrogen-cooled isopentane. Sections were air-dried, fixed with
acetone at 220uC for 20 min, rehydrated in PBS, incubated with
primary and secondary antibody (1 hr at 30uC, each followed by
three washes in PBS), and mounted in Pro-Long anti-fade medium
(Invitrogen) containing 1.5 mg/ml DAPI. Specimens were ana-
lyzed either with a Zeiss Axiovert S100 conventional epifluores-
cence microscope, or with a Zeiss 510 META confocal
microscope. For confocal microscopy specimens were imaged
using multi-track setting, in order to block bleed-through between
channels.
For immunoblotting, cultured cell lysates were prepared as
described previously [39]. To prepare lysates for immunoblotting,
mouse tissues fragments (0.2–0.5 g) were homogenized in 1–1.5
ml lysis buffer. For colon and kidney samples, we used Lysis Buffer
A: 50 mM Tris-HCl, pH 7.4, 100 mM sodium pyrophosphate,
100 mM NaF, 10 mM EDTA, 10 mM sodium orthovanadate,
2 mM PMSF, 1% Triton X-100, 1% SDS, 10 mM DTT, protease
inhibitor cocktail mix (1X, Roche). For other tissues, we used Lysis
Buffer B: 50 mM Tris-HCl, pH 9.5, 2% SDS, 65 mM DTT, 10%
glycerol. Tissues were homogenized at 4uC, and centrifuged at
PLEKHA7 Localization
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tants were mixed 1:1 with 26SDS sample buffer, boiled and
analyzed by SDS-PAGE. Gels were transferred onto nitrocellu-
lose, and nitrocellulose membranes were blocked in TBS-milk
(150 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.1% Tween-20, 5%
skimmed milk) for 1 hr, incubated with primary antibodies (16 hr
4uC), followed by HRP-coupled secondary antibodies (1 hr room
temperature) and development with West Pico chemiluminescent
substrate (Pierce).
Immunoelectron microscopy
Segments of mouse intestine were fixed with 4% formaldehyde
in 0.1 M phosphate buffer 20 min at room temperature, followed
by overnight incubation at 4uC. Fixed tissue was cut in small cubic
blocks (0.5 mm length), blocked in glycine (20 mM, in 0.1 M
phosphate buffer) and infiltrated with 2.3 M sucrose in 0.1 M
phosphate buffer. Ultrathin cryosections were prepared according
to [40]. Briefly, sections (60–100 nm) were cut on a Leica Ultracut
microtome at 2120uC, picked up with 2.3 M sucrose and placed
onto Formvar/carbon-coated copper grids. After blocking with
2% gelatine and then 1% BSA in PBS, sections were labelled with
affinity-purified rabbit-anti-PLEKHA7 antibody (diluted 1:30 in
PBS with 1% BSA). Affinity purification of polyclonal antibodies
was carried out by incubation of the serum with the antigen
immobilized on nitrocellulose, followed by elution of antibodies
with 200 mM Glycine-HCl, pH 2.8, and neutralization with Tris-
HCl pH 7.5. Visualization of antibodies on sections was
performed with 10-nm protein A-gold (obtained from G.
Posthuma, Cell Microscopy Center, Utrecht, The Netherlands)
diluted 1:40 in the same buffer. Sections were post-fixed, stained
and dried according to [41]. Specimens were examined on a
Tecnai G2 electron microscope (FEI, Eindhoven, the Netherlands)
at an accelerating voltage of 160 kV. Images were analyzed with
ImageJ software.
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